Back to Search
EDWARD GOSSELIN, MD FACEP
MD FACEP
Emergency Medicine Physician
NPI: 1821015330Individual
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
MD450663(PA)25MA05700800(NJ)
Research & Publications (12)
Differential requirements for protection against mucosal challenge with Francisella tularensis in the presence versus absence of cholera toxin B and inactivated F. tularensis.
PMID 19342669·J Immunol·2009
7-preclinical
Fourier transform infrared immunosensors for model hapten molecules.
PMID 19201185·Biosens Bioelectron·2009
8-other
Surface functionalization of germanium ATR devices for use in FTIR-biosensors.
PMID 19150721·J Colloid Interface Sci·2009
8-other
Utilization of Fc receptors as a mucosal vaccine strategy against an intracellular bacterium, Francisella tularensis.
PMID 18390739·J Immunol·2008
7-preclinical
Natural killer and CD8 T cells dominate the response by human peripheral blood mononuclear cells to inactivated Francisella tularensis live vaccine strain.
PMID 16386645·Hum Immunol·2005
4-observational
Enhanced antigen-specific antibody and cytokine responses when targeting antigen to human FcGAMMA receptor type I using an anti-human FcGAMMA receptor type I-streptavidin fusion protein in an adjuvant-free system.
PMID 16304730·Immunol Invest·2005
7-preclinical
Low-level signaling generated by FcgammaRIIB-B cell receptor co-ligation establishes a state of global B cell receptor nonresponsiveness.
PMID 15773572·Immunol Invest·2005
7-preclinical
Generation of a human IgG3-streptavidin fusion protein. Implications for the inhibition and elimination of auto-reactive B cells.
PMID 14646036·Hum Antibodies·2003
8-other
Production of genetically engineered biotinylated interleukin-2 and its application in a rapid nonradioactive assay for T-cell activation.
PMID 12738628·Clin Diagn Lab Immunol·2003
7-preclinical
A two-component modular approach for enhancing T-cell activation utilizing a unique anti-FcgammaRI-streptavidin construct and microspheres coated with biotinylated-antigen.
PMID 12485681·Biomol Eng·2003
8-other
Lipoteichoic acid inhibits interleukin-2 (IL-2) function by direct binding to IL-2.
PMID 11527813·Clin Diagn Lab Immunol·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1245 SHERLIN DR
BRIDGEWATER, NJ 08807 - Phone
- (908) 229-9268
Quick Facts
- NPI
- 1821015330
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 12
Are you this provider?
Claim Your Profile